13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D/A Filed 2026-09-15 Event 2026-09-14 SEC 0001062993-26-004967 →

Sharpe Jeffrey Nathan → Conexeu Sciences Inc. CNXU

Stake: — Shares: 1,500,000 Class: Common Stock
Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 23/100
  • Active Schedule 13D filer baseline
  • Short interest building (+41.2% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
5 13D/G filings on this issuer
4 other filings besides this one
Filer Track Record
2 filings by this filer
1 other filing in the data moat
Short Interest · settle 2026-10-15
DTC 1.00
297,243 shares short · +41.2% vs prior

Other 13D/G Filings on Conexeu Sciences Inc.

FiledFormFilerStakeShares
2026-09-04 SCHEDULE 13G Multi-Valor AIF Umbrella Fund SICAV Quintus Growth Fund — — view →
2026-08-18 SCHEDULE 13D Sharpe Jeffrey Nathan 5.40% 1,500,000 view →
2026-08-18 SCHEDULE 13G Bogart David Robert — — view →
2026-07-20 SCHEDULE 13G Paisley Capital Holdings Corp — — view →

Other Filings by Sharpe Jeffrey Nathan

FiledFormIssuerStakeShares
2026-08-18 SCHEDULE 13D Conexeu Sciences Inc. 5.40% 1,500,000 view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →